To provide excellence in patient care and leadership in scientific investigation of cutaneous lymphomas that will lead to greater knowledge and the development of new therapies to improve the survival and the quality of life of our patients.
The Stanford Multidsciplinary Cutaneous and T-Cell Lymphoma Team offers expert treatment for patients with cutaneous lymphomas, including mycosis fungoides, Sezary syndrome, CD30+ lymphoproliferative disorders (lymphomatoid papulosis and anaplastic large cell lymphoma), subcutaneous panniculitis-like T-cell lymphoma, gamma-delta T-cell lymphoma, CD8+ aggressive epidermotropic T-cell lymphoma, NK/T-cell lymphoma, other unspecified cutaneous peripheral T-cell lymphomas, and cutaneous B-cell lymphomas. Our physicians subspecialize in treating these types of cancers, and have extensive expertise in handling the most complicated cases. Care among specialists is tightly integrated.
- – Stanford Medicine
The rarest of rashes
Curing the skin's rogue cancer - Youn Kim, M.D. and members of the multidisciplinary cutaneous lymphoma team, their research and clinical care were featured in this Stanford Medicine Magazine article.
- – News Center
Researchers find mutations that contribute to rare blood cancer
Mutations in immune cells prevented their natural death in roughly half of the cell samples from patients with the incurable cancer, and suggest drug targets for the disease.
Dr. Youn Kim's Recent Presentations
Slides of Dr. Youn Kim's recent presentations
- Prospective Study to Establish a CL International Prognostic Index Model and Impact of Systemic Therapies in Advanced MF and SS (PROCLIPI)
- CLIC 2 Year Progress Report
- PROCLIPI NIH R01
- Managing MF and SS with Allogenetic HSCT